AI-assisted multiplex fluorescence sensing platform for grading diagnosis of Alzheimer’s disease

Q: What type of study is this?

This is a Experimental Study study.

Yibiao Liu; Zhongzeng Zhou; Xingyun Liu; Qiong Liu; Tailin Xu

doi:10.1039/d5tb01103e

January 1, 2025Journal of Materials Chemistry B

AI-assisted multiplex fluorescence sensing platform for grading diagnosis of Alzheimer’s disease

View at Publisher

Ask AI

Bookmark

Share

Key Points

AI-assisted platform enhances the diagnostic accuracy of blood biomarkers for Alzheimer's disease.
Diagnostic accuracy remains a challenge with single blood biomarkers due to individual variations.
Multiplex fluorescence sensing allows for multiple biomarkers to be assessed simultaneously, improving outcomes.
This approach could lead to more reliable diagnostic protocols for Alzheimer's disease going forward.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

AI-assisted technology improves biomarker accuracy for diagnosing Alzheimer's disease in patients.

Abstract

Blood-based biomarkers have become increasingly important for Alzheimer's disease (AD) diagnosis. However, due to individual variations, diagnostic accuracy using single blood biomarker remains low, making it challenging to implement in...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/68d462db31b076d99fa62a0b https://doi.org/10.1039/d5tb01103e

View at Publisher

Ask AI

Bookmark

Share

AI-assisted multiplex fluorescence sensing platform for grading diagnosis of Alzheimer’s disease

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

AI-assisted multiplex fluorescence sensing platform for grading diagnosis of Alzheimer’s disease

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading